by Jordana Choucair | Dec 12, 2022 | M&A
Amgen Inc. has agreed to buy biotechnology company Horizon Therapeutics PLC in a deal worth $27.8 billion, the largest health care acquisition of the year. The all-cash deal is equal to a nearly 20 percent premium over Horizon’s closing stock price on Friday....
by Jordana Choucair | Dec 12, 2022 | Providers
The Medicare Payment Advisory Commission (MedPAC) is poised to recommend that Congress increase 2024 Medicare payment to hospitals by 1 percent over what the law prescribes. The group is also likely to recommend a pay boost for clinicians paid through the physician...
by Jordana Choucair | Dec 9, 2022 | Access & Coverage
Senators Tammy Baldwin and Patty Murray introduced a bill that would help fund expenses for women who need to travel to undergo abortion procedures.The Reproductive Health Travel Fund Ac would authorize $350 million annually in grants over the next five years for...
by Jordana Choucair | Dec 9, 2022 | Life Sciences
The Mark Cuban Cost Plus Drug Co. and the Purchaser Business Group on Health’s EmansaRx jointly launched EmansaRx Plus, a pharmacy benefit manager (PBM) majority-owned by the business group that supplements employers’ existing drug benefits. EmansaRx Plus...
by Jordana Choucair | Dec 9, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized updated COVID-19 shots from Pfizer and Moderna that target the omicron variant for children as young as six months. Children between 6 months and 5 years old who received the Moderna primary series can receive the...
Recent Comments